表紙
市場調査レポート

デングウイルス - パイプライン製品の分析

Dengue Virus - Pipeline Review, 2015

発行 GlobalData 商品コード 341956
出版日 ページ情報 英文 51 Pages
即納可能
価格
本日の銀行送金レート: 1USD=105.42円で換算しております。
Back to Top
デングウイルス - パイプライン製品の分析 Dengue Virus - Pipeline Review, 2015
出版日: 2015年09月14日 ページ情報: 英文 51 Pages
概要

当レポートでは、デングウイルス診断検査のパイプライン製品について調査分析し、主要なパイプライン製品、主要企業、開発段階別のパイプライン製品、主な臨床試験データ、最近の動向について、体系的な情報を提供しています。

第1章 目次

第2章 イントロダクション

  • デングウイルスの概要

第3章 開発中の製品

  • デングウイルス - パイプライン製品:開発段階別
  • デングウイルス - パイプライン製品:地域別
  • デングウイルス - パイプライン製品:規制経路別
  • デングウイルス - パイプライン製品:承認時期別 (予定)

第4章 デングウイルス:開発中のパイプライン製品 (企業別)

  • デングウイルス企業 - パイプライン製品:開発段階別
  • デングウイルス - パイプライン製品:開発段階別

第5章 デングウイルス企業と製品の概要

  • Acobiom
  • Ceres Nanosciences, Inc.
  • Chembio Diagnostic Systems, Inc.
  • Corgenix Medical Corporation
  • Epistem Holdings Plc
  • FK-Biotecnologia SA
  • GeneFirst Ltd
  • InBios International, Inc.
  • Innova Biotechnology Co., Ltd.
  • InstantLabs Medical Diagnostics Corporation
  • Institut Pasteur
  • Malaysian Bio-Diagnostics Research Sdn Bhd
  • McGill University
  • Micronics, Inc. (of Sony Group)
  • Nanyang Technological University
  • National University of Singapore
  • NOWDiagnostics
  • QuantuMDx Group Limited
  • Quidel Corporation
  • Roche Diagnostics International Ltd.
  • Trinity Biotech Plc
  • Universitas Padjadjaran
  • University of California, Berkeley
  • University of Texas Medical Branch at Galveston
  • Vircell S.L
  • Whidiag SAS

第6章 デングウイルス:最近の動向

第7章 付録

図表

目次
Product Code: GDME0067EPD

GlobalData's Medical Devices sector report, "Dengue Virus - Pipeline Review, 2015" provides an overview of Dengue Virus diagnostic tests currently in pipeline stage.

The report provides comprehensive information on the pipeline products with comparative analysis of the products at various stages of development. The report reviews major players involved in the pipeline product development. It also provides information about clinical trials in progress, which includes trial phase, trial status, trial start and end dates, and, the number of trials for the key Dengue Virus diagnostic tests pipeline products.

This report is prepared using data sourced from in-house databases, secondary and primary research by GlobalData's team of industry experts.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data in relation to the equipment type.

Scope

  • Extensive coverage of the Dengue Virus diagnostic tests under development
  • The report reviews details of major pipeline products which includes, product description, licensing and collaboration details and other developmental activities
  • The report reviews the major players involved in the development of Dengue Virus diagnostic tests and list all their pipeline projects
  • The coverage of pipeline products based on various stages of development ranging from Early Development to Approved / Issued stage
  • The report provides key clinical trial data of ongoing trials specific to pipeline products
  • Recent developments in the segment / industry

Reasons to buy

The report enables you to -

  • Formulate significant competitor information, analysis, and insights to improve R&D strategies
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Identify and understand important and diverse types of Dengue Virus diagnostic tests under development
  • Develop market-entry and market expansion strategies
  • Plan mergers and acquisitions effectively by identifying major players with the most promising pipeline
  • In-depth analysis of the product's current stage of development, territory and estimated launch date

Table of Contents

1. Table of Contents

  • 1.1. List of Tables
  • 1.2. List of Figures

2. Introduction

  • 2.1. Dengue Virus Overview

3. Products under Development

  • 3.1. Dengue Virus - Pipeline Products by Stage of Development
  • 3.2. Dengue Virus - Pipeline Products by Territory
  • 3.3. Dengue Virus - Pipeline Products by Regulatory Path
  • 3.4. Dengue Virus - Pipeline Products by Estimated Approval Date

4. Dengue Virus - Pipeline Products under Development by Companies

  • 4.1. Dengue Virus Companies - Pipeline Products by Stage of Development
  • 4.2. Dengue Virus - Pipeline Products by Stage of Development

5. Dengue Virus Companies and Product Overview

  • 5.1. Acobiom Company Overview
    • 5.1.1. Acobiom Pipeline Products & Ongoing Clinical Trials Overview
  • 5.2. Ceres Nanosciences, Inc. Company Overview
    • 5.2.1. Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.3. Chembio Diagnostic Systems, Inc. Company Overview
    • 5.3.1. Chembio Diagnostic Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.4. Corgenix Medical Corporation Company Overview
    • 5.4.1. Corgenix Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.5. Epistem Holdings Plc Company Overview
    • 5.5.1. Epistem Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.6. FK-Biotecnologia SA Company Overview
    • 5.6.1. FK-Biotecnologia SA Pipeline Products & Ongoing Clinical Trials Overview
  • 5.7. GeneFirst Ltd Company Overview
    • 5.7.1. GeneFirst Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.8. InBios International, Inc. Company Overview
    • 5.8.1. InBios International, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.9. Innova Biotechnology Co., Ltd. Company Overview
    • 5.9.1. Innova Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.10. InstantLabs Medical Diagnostics Corporation Company Overview
    • 5.10.1. InstantLabs Medical Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.11. Institut Pasteur Company Overview
    • 5.11.1. Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview
  • 5.12. Malaysian Bio-Diagnostics Research Sdn Bhd Company Overview
    • 5.12.1. Malaysian Bio-Diagnostics Research Sdn Bhd Pipeline Products & Ongoing Clinical Trials Overview
  • 5.13. McGill University Company Overview
    • 5.13.1. McGill University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.14. Micronics, Inc. (of Sony Group) Company Overview
    • 5.14.1. Micronics, Inc. (of Sony Group) Pipeline Products & Ongoing Clinical Trials Overview
  • 5.15. Nanyang Technological University Company Overview
    • 5.15.1. Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview
  • 5.16. National University of Singapore Company Overview
    • 5.16.1. National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • 5.17. NOWDiagnostics Company Overview
    • 5.17.1. NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • 5.18. QuantuMDx Group Limited Company Overview
    • 5.18.1. QuantuMDx Group Limited Pipeline Products & Ongoing Clinical Trials Overview
  • 5.19. Quidel Corporation Company Overview
    • 5.19.1. Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • 5.20. Roche Diagnostics International Ltd. Company Overview
    • 5.20.1. Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • 5.21. Trinity Biotech Plc Company Overview
    • 5.21.1. Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
  • 5.22. Universitas Padjadjaran Company Overview
    • 5.22.1. Universitas Padjadjaran Pipeline Products & Ongoing Clinical Trials Overview
  • 5.23. University of California, Berkeley Company Overview
    • 5.23.1. University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview
  • 5.24. University of Texas Medical Branch at Galveston Company Overview
    • 5.24.1. University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • 5.25. Vircell S.L Company Overview
    • 5.25.1. Vircell S.L Pipeline Products & Ongoing Clinical Trials Overview
  • 5.26. Whidiag SAS Company Overview
    • 5.26.1. Whidiag SAS Pipeline Products & Ongoing Clinical Trials Overview

6. Dengue Virus- Recent Developments

7. Appendix

  • 7.1. Methodology
  • 7.2. About GlobalData
  • 7.3. Contact Us
  • 7.4. Disclaimer

List of Tables

  • Table 1: Dengue Virus - Pipeline Products by Stage of Development
  • Table 2: Dengue Virus - Pipeline Products by Territory
  • Table 3: Dengue Virus - Pipeline Products by Regulatory Path
  • Table 4: Dengue Virus - Pipeline Products by Estimated Approval Date
  • Table 5: Dengue Virus Companies - Pipeline Products by Stage of Development
  • Table 6: Dengue Virus - Pipeline Products by Stage of Development
  • Table 7: Acobiom Pipeline Products & Ongoing Clinical Trials Overview
  • Table 8: Diagnostic Test - Dengue - Product Status
  • Table 9: Diagnostic Test - Dengue - Product Description
  • Table 10: Ceres Nanosciences, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 11: Dengue Virus Test - Product Status
  • Table 12: Dengue Virus Test - Product Description
  • Table 13: Chembio Diagnostic Systems, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 14: DPP Dengue Fever Assay - Product Status
  • Table 15: DPP Dengue Fever Assay - Product Description
  • Table 16: Corgenix Medical Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 17: Dengue Virus Test Kit - Product Status
  • Table 18: Dengue Virus Test Kit - Product Description
  • Table 19: Epistem Holdings Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 20: Genedrive - Dengue Fever Assay - Product Status
  • Table 21: Genedrive - Dengue Fever Assay - Product Description
  • Table 22: FK-Biotecnologia SA Pipeline Products & Ongoing Clinical Trials Overview
  • Table 23: Point Of Care Test - Dengue Fever - Product Status
  • Table 24: Point Of Care Test - Dengue Fever - Product Description
  • Table 25: GeneFirst Ltd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 26: PCDR - Dengue Test - Product Status
  • Table 27: PCDR - Dengue Test - Product Description
  • Table 28: InBios International, Inc. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 29: DENV Detect IgA Capture ELISA - Product Status
  • Table 30: DENV Detect IgA Capture ELISA - Product Description
  • Table 31: Innova Biotechnology Co., Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 32: Rapid Test - Dengue Fever - Product Status
  • Table 33: Rapid Test - Dengue Fever - Product Description
  • Table 34: InstantLabs Medical Diagnostics Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 35: Multiple Assay Disposable Cartridge - Dengue Fever - Product Status
  • Table 36: Multiple Assay Disposable Cartridge - Dengue Fever - Product Description
  • Table 37: Institut Pasteur Pipeline Products & Ongoing Clinical Trials Overview
  • Table 38: Diagnostic Assay - Dengue - Product Status
  • Table 39: Diagnostic Assay - Dengue - Product Description
  • Table 40: Malaysian Bio-Diagnostics Research Sdn Bhd Pipeline Products & Ongoing Clinical Trials Overview
  • Table 41: Diagnostic Test - Dengue Fever - Product Status
  • Table 42: Diagnostic Test - Dengue Fever - Product Description
  • Table 43: McGill University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 44: Biomarker Assay - Dengue - Product Status
  • Table 45: Biomarker Assay - Dengue - Product Description
  • Table 46: Micronics, Inc. (of Sony Group) Pipeline Products & Ongoing Clinical Trials Overview
  • Table 47: Wallet Test - Dengue - Product Status
  • Table 48: Wallet Test - Dengue - Product Description
  • Table 49: Nanyang Technological University Pipeline Products & Ongoing Clinical Trials Overview
  • Table 50: Dengue Test Kit - Product Status
  • Table 51: Dengue Test Kit - Product Description
  • Table 52: National University of Singapore Pipeline Products & Ongoing Clinical Trials Overview
  • Table 53: Dengue Prognostic Test Kit - Product Status
  • Table 54: Dengue Prognostic Test Kit - Product Description
  • Table 55: NOWDiagnostics Pipeline Products & Ongoing Clinical Trials Overview
  • Table 56: ADEXUSDx Test - Dengue - Product Status
  • Table 57: ADEXUSDx Test - Dengue - Product Description
  • Table 58: QuantuMDx Group Limited Pipeline Products & Ongoing Clinical Trials Overview
  • Table 59: Q-POC - Dengue Fever Assay - Product Status
  • Table 60: Q-POC - Dengue Fever Assay - Product Description
  • Table 61: Quidel Corporation Pipeline Products & Ongoing Clinical Trials Overview
  • Table 62: IsoAmp Assay - Dengue - Product Status
  • Table 63: IsoAmp Assay - Dengue - Product Description
  • Table 64: Roche Diagnostics International Ltd. Pipeline Products & Ongoing Clinical Trials Overview
  • Table 65: Liat Dengue Assay - Product Status
  • Table 66: Liat Dengue Assay - Product Description
  • Table 67: Trinity Biotech Plc Pipeline Products & Ongoing Clinical Trials Overview
  • Table 68: Diagnostic Assay - Dengue - Product Status
  • Table 69: Diagnostic Assay - Dengue - Product Description
  • Table 70: Universitas Padjadjaran Pipeline Products & Ongoing Clinical Trials Overview
  • Table 71: Rapid Molecular Assay - Dengue - Product Status
  • Table 72: Rapid Molecular Assay - Dengue - Product Description
  • Table 73: University of California, Berkeley Pipeline Products & Ongoing Clinical Trials Overview
  • Table 74: Diagnostic Assay - Dengue Virus - Product Status
  • Table 75: Diagnostic Assay - Dengue Virus - Product Description
  • Table 76: University of Texas Medical Branch at Galveston Pipeline Products & Ongoing Clinical Trials Overview
  • Table 77: Biomarker Based Assay - Dengue Virus Infection - Product Status
  • Table 78: Biomarker Based Assay - Dengue Virus Infection - Product Description
  • Table 79: Vircell S.L Pipeline Products & Ongoing Clinical Trials Overview
  • Table 80: VIRapid Dengue DUO (Ag+Ab) Test - Product Status
  • Table 81: VIRapid Dengue DUO (Ag+Ab) Test - Product Description
  • Table 82: Whidiag SAS Pipeline Products & Ongoing Clinical Trials Overview
  • Table 83: Rapid Diagnostic Test - Dengue Virus - Product Status
  • Table 84: Rapid Diagnostic Test - Dengue Virus - Product Description
  • Table 85: Glossary

List of Figures

  • Figure 1: Dengue Virus - Pipeline Products by Stage of Development
  • Figure 2: Dengue Virus - Pipeline Products by Territory
  • Figure 3: Dengue Virus - Pipeline Products by Regulatory Path
  • Figure 4: Dengue Virus - Pipeline Products by Estimated Approval Date
Back to Top